Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s10875-005-7828-2.

Title:
Protective Molecules–C-Reactive Protein (CRP), Serum Amyloid P (SAP), Pentraxin3 (PTX3), Mannose-Binding Lectin (MBL), and Apolipoprotein A1 (Apo A1), and Their Autoantibodies: Prevalence and Clinical Significance in Autoimmunity | Journal of Clinical Immunology
Description:
Apoptotic defects and impaired clearance of cellular debris are considered key events in the development of autoimmunity, as they can contribute to autoantigen overload, and may initiate an autoimmune response. The pentraxins are a group of highly conserved proteins including the short pentraxins, C-reactive protein (CRP) and serum amyloid-P (SAP), and the long pentraxin-3 (PTX3), which are all involved in innate immunity and in acute-phase responses. Mannan-binding lectin (MBL) is an activator of the complement system, and Apolipoprotein A-1 (Apo A-1) is pivotal in the cholesterol homeostasis and has anti-inflammatory properties. In addition to their role in innate immunity and inflammation, each of these five proteins participates in the removal of damaged and apoptotic cells. In this review, we discuss the clinical significance of different levels of these proteins, their role in the induction or protection from autoimmunity, and the presence of specific autoantibodies against them in the different autoimmune diseases.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 8,170,236 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't see how the site brings in money.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

google, scholar, cas, pubmed, article, protein, lectin, creactive, systemic, lupus, immunol, mannosebinding, erythematosus, arthritis, pentraxin, ptx, patients, mantovani, serum, amyloid, autoimmunity, long, med, disease, cells, shoenfeld, binding, peri, rheum, garred, madsen, autoantibodies, apoptotic, role, exp, clin, rheumatoid, bottazzi, mannose, apolipoprotein, autoimmune, pepys, biol, gene, pentraxins, proteins, innate, inflammation, diseases, production,

Topics {✒️}

protective molecules–c-reactive protein complement-dependent acute-phase expression month download article/chapter mannose-binding lectin deficiency—revisited anti-inflammatory properties rabbit c-reactive protein mannose-binding lectin gene acute-phase proteins mannose-binding lectin genotypes considered key events anti-serum amyloid mannose-binding lectin insufficiency laura schwatz-kipp chair monomeric c-reactive protein anti-apolipoprotein a c-reactive protein binds c-reactive protein expression mannose-binding lectin polymorphisms mannose-binding-lectin deficiency antigen-presenting dendritic cells acute phase response van gijlswijk-janssen dj end-stage renal disease long pentraxin ptx3—similarities mannan-binding lectin pathway acute-phase responses full article pdf low mbl production mannose-binding protein mannose-binding lectin mannose binding lectin clinical immunology aims c-reactive protein regulates tissue factor privacy choices/manage cookies acute coronary syndrome f1 mice expressing mannan-binding lectin mannan binding lectin o'hara bp cell surface calreticulin acute myocardial infarction long pentraxin ptx3 article kravitz human endothelial cells systemic lupus erythematosus check access instant access terminal complement components prototypical long pentraxin

Questions {❓}

  • Arici M, Walls J: End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?
  • Bresnihan B, Gogarty M, Fitzgerald O, Dayer JM, Burger D: Apolipoprotein A-I infiltration in rheumatoid arthritis synovial tissue: A control mechanism of cytokine production?
  • Burger D, Dayer JM: High-density lipoprotein-associated apolipoprotein A-I: The missing link between infection and chronic inflammation?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Protective Molecules–C-Reactive Protein (CRP), Serum Amyloid P (SAP), Pentraxin3 (PTX3), Mannose-Binding Lectin (MBL), and Apolipoprotein A1 (Apo A1), and Their Autoantibodies: Prevalence and Clinical Significance in Autoimmunity
         description:Apoptotic defects and impaired clearance of cellular debris are considered key events in the development of autoimmunity, as they can contribute to autoantigen overload, and may initiate an autoimmune response. The pentraxins are a group of highly conserved proteins including the short pentraxins, C-reactive protein (CRP) and serum amyloid-P (SAP), and the long pentraxin-3 (PTX3), which are all involved in innate immunity and in acute-phase responses. Mannan-binding lectin (MBL) is an activator of the complement system, and Apolipoprotein A-1 (Apo A-1) is pivotal in the cholesterol homeostasis and has anti-inflammatory properties. In addition to their role in innate immunity and inflammation, each of these five proteins participates in the removal of damaged and apoptotic cells. In this review, we discuss the clinical significance of different levels of these proteins, their role in the induction or protection from autoimmunity, and the presence of specific autoantibodies against them in the different autoimmune diseases.
         datePublished:
         dateModified:
         pageStart:582
         pageEnd:591
         sameAs:https://doi.org/10.1007/s10875-005-7828-2
         keywords:
            Acute-phase proteins
            anti-CRP
            anti-SAP
            anti-PTX3
            anti-MBL
            anti ApoA1
            autoimmunity
            Immunology
            Infectious Diseases
            Internal Medicine
            Medical Microbiology
         image:
         isPartOf:
            name:Journal of Clinical Immunology
            issn:
               1573-2592
               0271-9142
            volumeNumber:25
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Kluwer Academic Publishers-Plenum Publishers
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Martine Szyper Kravitz
               affiliation:
                     name:Tel Aviv University
                     address:
                        name:Center for Autoimmune Diseases and Department of Medicine B, Chaim Sheba Medical Center Tel-Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Milena Pitashny
               affiliation:
                     name:Tel Aviv University
                     address:
                        name:Center for Autoimmune Diseases and Department of Medicine B, Chaim Sheba Medical Center Tel-Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yehuda Shoenfeld
               affiliation:
                     name:Tel Aviv University
                     address:
                        name:Center for Autoimmune Diseases and Department of Medicine B, Chaim Sheba Medical Center Tel-Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
                        type:PostalAddress
                     type:Organization
                     name:TelAviv University
                     address:
                        name:Incumbent of the Laura Schwatz-Kipp chair for autoimmunity, TelAviv University, Tel Aviv, Israel
                        type:PostalAddress
                     type:Organization
                     name:Chaim Sheba Medical Center
                     address:
                        name:Department of Medicine B, Chaim Sheba Medical Center, Tel-Hashomer, Israel
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Protective Molecules–C-Reactive Protein (CRP), Serum Amyloid P (SAP), Pentraxin3 (PTX3), Mannose-Binding Lectin (MBL), and Apolipoprotein A1 (Apo A1), and Their Autoantibodies: Prevalence and Clinical Significance in Autoimmunity
      description:Apoptotic defects and impaired clearance of cellular debris are considered key events in the development of autoimmunity, as they can contribute to autoantigen overload, and may initiate an autoimmune response. The pentraxins are a group of highly conserved proteins including the short pentraxins, C-reactive protein (CRP) and serum amyloid-P (SAP), and the long pentraxin-3 (PTX3), which are all involved in innate immunity and in acute-phase responses. Mannan-binding lectin (MBL) is an activator of the complement system, and Apolipoprotein A-1 (Apo A-1) is pivotal in the cholesterol homeostasis and has anti-inflammatory properties. In addition to their role in innate immunity and inflammation, each of these five proteins participates in the removal of damaged and apoptotic cells. In this review, we discuss the clinical significance of different levels of these proteins, their role in the induction or protection from autoimmunity, and the presence of specific autoantibodies against them in the different autoimmune diseases.
      datePublished:
      dateModified:
      pageStart:582
      pageEnd:591
      sameAs:https://doi.org/10.1007/s10875-005-7828-2
      keywords:
         Acute-phase proteins
         anti-CRP
         anti-SAP
         anti-PTX3
         anti-MBL
         anti ApoA1
         autoimmunity
         Immunology
         Infectious Diseases
         Internal Medicine
         Medical Microbiology
      image:
      isPartOf:
         name:Journal of Clinical Immunology
         issn:
            1573-2592
            0271-9142
         volumeNumber:25
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Kluwer Academic Publishers-Plenum Publishers
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Martine Szyper Kravitz
            affiliation:
                  name:Tel Aviv University
                  address:
                     name:Center for Autoimmune Diseases and Department of Medicine B, Chaim Sheba Medical Center Tel-Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Milena Pitashny
            affiliation:
                  name:Tel Aviv University
                  address:
                     name:Center for Autoimmune Diseases and Department of Medicine B, Chaim Sheba Medical Center Tel-Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yehuda Shoenfeld
            affiliation:
                  name:Tel Aviv University
                  address:
                     name:Center for Autoimmune Diseases and Department of Medicine B, Chaim Sheba Medical Center Tel-Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
                     type:PostalAddress
                  type:Organization
                  name:TelAviv University
                  address:
                     name:Incumbent of the Laura Schwatz-Kipp chair for autoimmunity, TelAviv University, Tel Aviv, Israel
                     type:PostalAddress
                  type:Organization
                  name:Chaim Sheba Medical Center
                  address:
                     name:Department of Medicine B, Chaim Sheba Medical Center, Tel-Hashomer, Israel
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Journal of Clinical Immunology
      issn:
         1573-2592
         0271-9142
      volumeNumber:25
Organization:
      name:Kluwer Academic Publishers-Plenum Publishers
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Tel Aviv University
      address:
         name:Center for Autoimmune Diseases and Department of Medicine B, Chaim Sheba Medical Center Tel-Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
         type:PostalAddress
      name:Tel Aviv University
      address:
         name:Center for Autoimmune Diseases and Department of Medicine B, Chaim Sheba Medical Center Tel-Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
         type:PostalAddress
      name:Tel Aviv University
      address:
         name:Center for Autoimmune Diseases and Department of Medicine B, Chaim Sheba Medical Center Tel-Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
         type:PostalAddress
      name:TelAviv University
      address:
         name:Incumbent of the Laura Schwatz-Kipp chair for autoimmunity, TelAviv University, Tel Aviv, Israel
         type:PostalAddress
      name:Chaim Sheba Medical Center
      address:
         name:Department of Medicine B, Chaim Sheba Medical Center, Tel-Hashomer, Israel
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Martine Szyper Kravitz
      affiliation:
            name:Tel Aviv University
            address:
               name:Center for Autoimmune Diseases and Department of Medicine B, Chaim Sheba Medical Center Tel-Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
               type:PostalAddress
            type:Organization
      name:Milena Pitashny
      affiliation:
            name:Tel Aviv University
            address:
               name:Center for Autoimmune Diseases and Department of Medicine B, Chaim Sheba Medical Center Tel-Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
               type:PostalAddress
            type:Organization
      name:Yehuda Shoenfeld
      affiliation:
            name:Tel Aviv University
            address:
               name:Center for Autoimmune Diseases and Department of Medicine B, Chaim Sheba Medical Center Tel-Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
               type:PostalAddress
            type:Organization
            name:TelAviv University
            address:
               name:Incumbent of the Laura Schwatz-Kipp chair for autoimmunity, TelAviv University, Tel Aviv, Israel
               type:PostalAddress
            type:Organization
            name:Chaim Sheba Medical Center
            address:
               name:Department of Medicine B, Chaim Sheba Medical Center, Tel-Hashomer, Israel
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Center for Autoimmune Diseases and Department of Medicine B, Chaim Sheba Medical Center Tel-Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
      name:Center for Autoimmune Diseases and Department of Medicine B, Chaim Sheba Medical Center Tel-Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
      name:Center for Autoimmune Diseases and Department of Medicine B, Chaim Sheba Medical Center Tel-Hashomer, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
      name:Incumbent of the Laura Schwatz-Kipp chair for autoimmunity, TelAviv University, Tel Aviv, Israel
      name:Department of Medicine B, Chaim Sheba Medical Center, Tel-Hashomer, Israel
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(251)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

3.76s.